ENZO BIOCHEM INC.
ENZO BIOCHEM INC.
- USD (-)
- 15 min delayed data - NYSE Stocks
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: ENZ
ISIN:

Federman & Sherwood Investigates Enzo Biochem for Data Breach

  • 127

The law firm of Federman & Sherwood has initiated an investigation into Enzo Biochem with respect to their recent data breach. On May 30, 2023, Enzo Biochem notified 2.47 million patients that the company experienced a data breach after an unauthorized party accessed sensitive consumer data entrusted to the company. According to Enzo Biochem, they determined that information stored on their servers may have been subject to unauthorized access on April 6, 2023. Enzo Biochem determined that the information exposed in the data breach includes: names, addresses, Social Security numbers, driver’s license numbers, financial information, medical information and health insurance information.

If you wish to discuss this action, obtain further information, and/or participate in this litigation, please contact Lacrista A. Bagley either by email at [email protected] or visit our firm’s website www.federmanlaw.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230602005305/en/

Business Wire
Business Wire
Business Wire, acquired by Berkshire Hathaway in 2006, is the global market leader in commercial news distribution. Thousands of member companies and organizations depend on Business Wire to transmit their full-text press releases, regulatory filings, photos and other multimedia content to journalists, financial professionals, investor services, regulatory authorities and consumers worldwide.